SCHEMBL2908677

SCHEMBL2908677

CC(C)(C)c1cc(CCCO)cc(C2(C)CCCCC2)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 4/20 0.40
TDP1 Q9NUW8 1/20 0.40
TSHR P16473 4/20 0.39
GLA P06280 1/20 0.39
ALOX12 P18054 1/20 0.39
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38
MAPK1 P28482 2/20 0.38
GSR P00390 2/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GAA P10253 5/20 0.37
LMNA P02545 3/20 0.37
POLB P06746 1/20 0.37
THRB P10828 1/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
ATM Q13315 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7933369 0.92 ALDH1A1 (0.41) ALDH1A1KDM4ETDP1TSHRGLA
SCHEMBL11806647 0.85 ALDH1A1 (0.40) ALDH1A1KDM4ETDP1TSHRGLA
SCHEMBL7942634 0.85 TNKS2 (0.33) ALDH1A1KDM4ETDP1TSHRGLA
SCHEMBL6567008 0.84 TNKS2 (0.36) TNKS2
SCHEMBL2911296 0.82 GLA (0.44) TSHRGLAALOX12GAAKMT2A
SCHEMBL7792145 0.82 GAA (0.45) ALDH1A1KDM4ETDP1TSHRGLA
SCHEMBL13899762 0.81 GLA (0.46) TSHRGLAALOX12GAAKMT2A
SCHEMBL7933911 0.81 GAA (0.39) ALDH1A1KDM4ETDP1TSHRGLA
SCHEMBL2916191 0.80 GLA (0.45) TSHRGLAALOX12GAAKMT2A
SCHEMBL11806638 0.80 ALDH1A1 (0.40) ALDH1A1KDM4ETDP1TSHRGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2110370-B1 Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL CO (JP) 2010-09-01 EP disclosed
EP-1348686-B1 Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL CO (JP) 2010-03-03 EP disclosed
EP-2110370-A1 Method of producing p-hydroxyphenylalkanols Sumitomo Chemical Company, Limited (JP) 2009-10-21 EP disclosed
CN-1572795-A Process for producing phosphite SUMITOMO CHEMICAL CO (JP) 2005-02-02 CN disclosed
EP-1484334-A2 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-08 EP disclosed
US-20040225145-A1 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED 2004-11-11 US disclosed
US-6717020-B2 HIGH YIELD REACTION OF PHENOLS AND UNSATURATED ALCOHOLS IN PRESENCE OF SUCH AS TITANIUM TETRAETHOXIDE AND SODIUM METHOXIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-04-06 US disclosed
US-20030195379-A1 Method of producing p-Hydroxyphenylalkanols SUMITOMO CHEMICAL COMPANY, LIMITED 2003-10-16 US disclosed
EP-1348686-A1 Method of producing p-hydroxyphenylalkanols SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-01 EP disclosed
EP-0823435-B1 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL CO (JP) 2001-11-21 EP disclosed
US-5914361-A IMPART HEAT STABILITY TO ORGANIC MATERIALS, INCLUDING POLYOLEFINS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-06-22 US disclosed
EP-0823435-A2 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-02-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195379-A1 Method of producing p-Hydroxyphenylalkanols ADH1C, NR1H3, ADH5 ALDH1A1 135/4885KDM4E 3412/4885TDP1 4114/4885
US-20040225145-A1 Process for producing phosphite PHOSPHO1, PLCG1, PLCG2 ALDH1A1 4488/4885KDM4E 2923/4885TDP1 4848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.